Skip to main content

Table 2 Antibiotic resistance patterns in E. faecalis isolates form urine and fecal specimens inpatients with community acquired-UTIs

From: Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection

Antibiotic resistance patternsa

Urine samples

N = 63 (%)

Fecal samples

N = 63 (%)

Same resistance patternsb

TET, MIN, GM120, CP, LEV, GAT

5 (7.9%)

2 (3.1%)

2

TET, MN, GM120, CP

2 (3.1%)

0 (0%)

0

TET, MN, GM120

10 (15.8%)

8 (12.6%)

7

TET, MN, CP, LEV, GAT

3 (4.7%)

0 (0%)

0

TET, MN, CP, GAT

0 (0%)

1 (1.5%)

0

TET, MN, CP, LEV

0 (0%)

1 (1.5%)

0

TET, CP, LEV, GAT

0 (0%)

1 (1.5%)

0

TET, MN, CP

2 (3.1%)

2 (3.1%)

1

TET, MN

33 (52.3%)

31 (49.2%)

25

CP, LEV

1 (1.5%)

0 (0%)

0

TET

1 (1.5%)

2 (3.1%)

1

GM120

1 (1.5%)

0 (0%)

0

No resistance

4 (6.3%)

15 (23.8%)

3

  1. aTET, tetracycline; MIN, minocycline; GM120, gentamicin 120 µg; CP, ciprofloxacin; LEV, levofloxacin; GAT, gatifloxacin. Resistance phenotypes were determined for all antibiotics, except daptomycin, by disk diffusion (Kirby–Bauer) method according to CLSI 2014 guidelines (MastGroupLtd, United Kingdom). Antibiotic concentration for each disk was as follows: Penicillin G (10 units), ampicillin (10 µg), vancomycin (30 µg), tetracycline (30 µg), minocycline (30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), gatifloxacin (5 µg), nitrofurantoin (300 µg), high level gentamicin-resistant enterococci (HLGRE, 120 µg) and linezolid (30 µg)
  2. bPatients with similar resistance patterns in both fecal and urine samples